Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Cash from Financing Activities: 2013-2025

Historic Cash from Financing Activities for Theravance Biopharma (TBPH) over the last 13 years, with Sep 2025 value amounting to -$400,000.

  • Theravance Biopharma's Cash from Financing Activities fell 7.53% to -$400,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year increase of 93.52%. This contributed to the annual value of -$2.5 million for FY2024, which is 98.74% up from last year.
  • Per Theravance Biopharma's latest filing, its Cash from Financing Activities stood at -$400,000 for Q3 2025, which was up 20.48% from -$503,000 recorded in Q2 2025.
  • Theravance Biopharma's Cash from Financing Activities' 5-year high stood at $105.3 million during Q2 2021, with a 5-year trough of -$722.0 million in Q3 2022.
  • In the last 3 years, Theravance Biopharma's Cash from Financing Activities had a median value of -$854,000 in 2025 and averaged -$18.5 million.
  • Per our database at Business Quant, Theravance Biopharma's Cash from Financing Activities spiked by 5,521.20% in 2021 and then slumped by 57,728.57% in 2023.
  • Theravance Biopharma's Cash from Financing Activities (Quarterly) stood at $149,000 in 2021, then slumped by 23,906.71% to -$35.5 million in 2022, then increased by 13.71% to -$30.6 million in 2023, then surged by 98.81% to -$365,000 in 2024, then declined by 7.53% to -$400,000 in 2025.
  • Its Cash from Financing Activities was -$400,000 in Q3 2025, compared to -$503,000 in Q2 2025 and -$854,000 in Q1 2025.